Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States
Publication
, Conference
Kang, H-R; Hernandez-Con, P; Heo, JH; Blake, K; Lang, JE; Wilson, D; Park, H
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
2023
Duke Scholars
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2023
Volume
32
Start / End Page
557 / 557
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kang, H.-R., Hernandez-Con, P., Heo, J. H., Blake, K., Lang, J. E., Wilson, D., & Park, H. (2023). Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 32, pp. 557–557).
Kang, Hye-Rim, Pilar Hernandez-Con, Ji Haeng Heo, Kathryn Blake, Jason E. Lang, Debbie Wilson, and Haesuk Park. “Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 32:557–557, 2023.
Kang H-R, Hernandez-Con P, Heo JH, Blake K, Lang JE, Wilson D, et al. Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023. p. 557–557.
Kang, Hye-Rim, et al. “Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 32, 2023, pp. 557–557.
Kang H-R, Hernandez-Con P, Heo JH, Blake K, Lang JE, Wilson D, Park H. Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023. p. 557–557.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2023
Volume
32
Start / End Page
557 / 557
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences